1. Jeyakumar, N, Etchegaray, M, Henry, J, et al. The terrible triad of checkpoint inhibition: a case report of myasthenia gravis, myocarditis, and myositis induced by cemiplimab in a patient with metastatic cutaneous squamous cell carcinoma. Case Reports Immunol 2020; 2020: 5126717.
Google Scholar | Crossref | Medline2. Cuzzubbo, S, Javeri, F, Tissier, M, et al. Neurological adverse events associated with immune checkpoint inhibitors: review of the literature. Eur J Cancer 2017; 73: 1–8.
Google Scholar | Crossref | Medline3. Shi, J, Niu, J, Shen, D, et al. Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor-related adverse reactions in the nervous system. Thorac Cancer 2020; 11: 481–487.
Google Scholar | Crossref | Medline4. Spain, L, Walls, G, Julve, M, et al. Neurotoxicity from immune-checkpoint inhibition in the treatment of melanoma: a single centre experience and review of the literature. Ann Oncol 2017; 28: 377–385.
Google Scholar | Crossref | Medline5. Zimmer, L, Goldinger, SM, Hofmann, L, et al. Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy. Eur J Cancer 2016; 60: 210–225.
Google Scholar | Crossref | Medline6. Makarious, D, Horwood, K, Coward, JIG. Myasthenia gravis: an emerging toxicity of immune checkpoint inhibitors. Eur J Cancer 2017; 82: 128–136.
Google Scholar | Crossref | Medline7. Safa, H, Johnson, DH, Trinh, VA, et al. Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature. J Immunother Cancer 2019; 7: 319.
Google Scholar | Crossref | Medline8. Yuen, C, Fleming, G, Meyers, M, et al. Myasthenia gravis induced by avelumab. Immunotherapy 2019; 11: 1181–1185.
Google Scholar | Crossref | Medline9. Brahmer, JR, Lacchetti, C, Schneider, BJ, et al. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 2018; 36: 1714–1768.
Google Scholar | Crossref | Medline10. Miller, RG, Milner-Brown, HS, Mirka, A. Prednisone-induced worsening of neuromuscular function in myasthenia gravis. Neurology 1986; 36: 729–732.
Google Scholar | Crossref | Medline